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For selected patients with malignant mesothelioma, treat-ment with extrapleural pneumonectomy (EPP), chemother-apy, and hemithoracic irradiation (trimodality therapy) ap-pears to confer improved survival relative to other treatment
options.1 Sugarbaker and colleagues1 demonstrated a 5-year survival
of 46%, with a median survival of 51 months, for patients with
epithelial histologic type, negative extrapleural nodes, and negative
resection margins. We therefore offer trimodality therapy to selected
patients with stage 1 (limited to one hemithorax) epithelial malignant
mesothelioma. All patients have preoperative computed tomographic
(CT), magnetic resonance imaging (MRI), and positron emission
tomographic (PET) scans.1,2 However, EPP is only offered to those
with histologically confirmed negative results of biopsy examinations
of the mediastinum, contralateral pleura, and diaphragmatic
peritoneum.
Clinical Summary
A 67-year-old woman was incidentally discovered to have a right
pleural effusion. Cytologic examination confirmed malignant me-
sothelioma. CT, MRI, and PET scans (Figure 1, A-C), demon-
strated stage 1 disease. The patient met established criteria for
trimodality therapy.1
Our staging protocol included mediastinoscopy, bilateral thoracos-
copy, and laparoscopy, with respective biopsy samples. Mediastinos-
copy revealed normal nodes. A left thoracoscopic sample was mac-
roscopically normal; random specimens were taken from three
midaxillary costal sites: superior, midzone, and inferior. Laparoscopy
revealed a 3-mm wide, gray, flat nodule on the dome of the right
diaphragm. Right thoracoscopy confirmed extensive malignant me-
sothelioma involving parietal and visceral pleura. Histopathologic
examination revealed normal mediastinal nodes. Epithelial malignant
mesothelioma was present in the right pleural, all left pleural (Figure
1, D), and the diaphragmatic biopsy specimens. Cytologic examina-
tion of peritoneal lavage fluid yielded negative results. The disease
was therefore restaged as stage 3, and the patient was offered
chemotherapy.
Discussion
The optimal management of stage 1 malignant mesothelioma is
unclear. EPP is an operation associated with significant mortal-
ity (10%-30%) and morbidity. Sugarbaker and colleagues2 have
reduced perioperative mortality for EPP to 5% with trimodality
therapy and have reported unequalled survival in selected cases
of malignant mesothelioma.2
Patterns of tumor recurrence after trimodality therapy reveal
that 26% recur in the peritoneum. Conventional wisdom sug-
gests the mechanism may relate to peritoneal seeding during
surgery. However, 17% of malignant mesothelioma recurrences
are in the contralateral pleura, and importantly, distant metas-
tases are rare.3 This suggests that preoperative understaging
may actually have occurred. Because of the significant morbid-
ity associated with this radical protocol, the finite sensitivities
of current imaging modalities, and the intimate (1 mm) ana-
tomic relations of both parietal pleura, the mediastinum, and
peritoneum, we advocate bilateral thoracoscopy, mediastinos-
copy, and laparoscopy, with respective biopsy samples, as
integral to correctly staging malignant mesothelioma.
This case is important because it emphasizes that surgical
preoperative staging appears necessary to prevent radical treat-
ment of patients who would not actually benefit and that current
nonsurgical staging procedures are not yet sufficiently sensitive
to replace surgical staging. The sensitivity of noninvasive im-
aging is limited in low-volume or micrometastatic disease.
State-of-the-art multislice CT, MRI, and PET scans were unable
to detect transdiaphragmatic or contralateral pleural disease,
and the pleura even appeared normal on visual inspection at
thoracoscopy.
We offer trimodality therapy only to patients with epithelial
histologic type. Surgical pleural biopsy is thus needed. Unilat-
eral thoracoscopy, mediastinoscopy, and laparoscopy and con-
tralateral thoracoscopy are performed. Operating time ap-
proaches 1 hour. Potential morbidity from these additional
procedures appears justified by the profound impact that a
positive result confers on treatment and prognosis. Our findings
are important not only to centers offering trimodality therapy
but also for staging malignant mesothelioma in general. Incor-
rect staging will invalidate trimodality therapy and subject
patients to unnecessary, painful, and potentially harmful com-
plications. Correct staging can only be achieved by a protocol
that includes mediastinoscopy, laparoscopy, and bilateral
thoracoscopy.
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Figure 1. A, CT scan. Axial postcontrast image at the level of the pulmonary trunk bifurcation. Right-sided
pleural effusion is present without discernible pleural mass. Left pleural surface is unremarkable. B, MRI
scan. Coronal T2-weighted half-Fourier acquisition single-shot turbo spin-echo (HASTE) through the carina.
Right-sided pleural effusion is present; no discernible pleural mass is evident. Left pleura is normal. C, PET
scan. Intense uptake along the right mediastinal pleura and right-sided effusion. The left pleura appears
normal. D, Thin ribbons of malignant mesothelioma cells infiltrating between layers of collagen; in addition,
surface mesothelial cells (not shown) show patchy foci of membranous staining to epithelial membrane
antigen within enlarged, atypical mesothelial cells.
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